hyponatremia during subarachnoid hemorrhage
Conditions
Brief summary
Change in natraemia in mmol/L measured before and on day of treatment discontinuation
Detailed description
Compare the sodium intake required to correct natraemia, Study the mechanism of action of urea, Évaluer l’impact du traitement sur la durée de séjour, Évaluer l’impact du traitement sur le devenir neurologique à 3 mois de l’inclusion, Assessing adverse effects of treatment, Persistence of natraemia correction 48H after discontinuation of treatment, Comparison of speed of correction of natraemia
Interventions
DRUGergytonyl placebo
DRUGUrea
Sponsors
Centre Hospitalier Universitaire Grenoble Alpes
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in natraemia in mmol/L measured before and on day of treatment discontinuation | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare the sodium intake required to correct natraemia, Study the mechanism of action of urea, Évaluer l’impact du traitement sur la durée de séjour, Évaluer l’impact du traitement sur le devenir neurologique à 3 mois de l’inclusion, Assessing adverse effects of treatment, Persistence of natraemia correction 48H after discontinuation of treatment, Comparison of speed of correction of natraemia | — |
Countries
France
Outcome results
None listed